Ferritin and the iron panel on TRT: what donating blood costs you

Testosterone lowers your ferritin before anyone takes a unit off you. The standard fix for a high haematocrit then removes 200 to 250 mg of iron at a time, every eight weeks, indefinitely — and the fatigue that follows looks exactly like the low-testosterone picture you started therapy to fix.

Testosterone moves iron before anything removes it

Ferritin is the protein your body stores iron in. A small fraction of it leaks into the blood, and that is what a ferritin test measures — an indirect read on the size of the reserve rather than on how much iron is in circulation at the moment of the draw. It is reported in ng/mL on most panels and in µg/L on others; those are the same number, so a result of 45 on one report and 45 on another needs no conversion between them.

Established clinical use Testosterone does two things to iron at once. It raises erythropoietin, which increases demand for iron, and it suppresses hepcidin, the hormone that gates iron out of storage and out of the gut. In men given testosterone, hepcidin and ferritin both fell measurably at one and three months while haemoglobin and haematocrit rose, and the fall in hepcidin tracked the rise in red cells ¹. Iron is being unlocked from stores and built into haemoglobin.

The practical consequence is that a ferritin that drops during the first months of therapy is expected, and it is not by itself evidence that you are losing iron. Redistribution and depletion both lower ferritin. Ferritin on its own cannot tell them apart. The rest of the panel can, which is the entire reason for ordering it instead of a single number.

What a unit of blood actually costs

Established clinical use A whole blood donation removes roughly 200 to 250 mg of iron along with the red cells, and replacing that from an ordinary diet takes more than 24 weeks without supplementation ². The minimum interval most collection services allow is eight weeks. The arithmetic is not subtle: donating at the permitted frequency removes iron about three times faster than food replaces it. The enrolment data from the REDS-II Donor Iron Status Evaluation study bear this out — among frequent male donors, 16.4% had no measurable iron stores and 48.7% showed iron-deficient erythropoiesis ³. Those are healthy volunteers with no reason to be iron deficient other than the donations themselves.

Established clinical use Now put that next to the reason people on testosterone end up donating in the first place. The 2018 Endocrine Society clinical practice guideline recommends withholding therapy above a haematocrit of 54% until the value normalises before resuming at a lower dose; therapeutic phlebotomy appears among the management options described ⁴. That is a haematocrit protocol. It does not arrive with an iron-monitoring schedule attached, and no compound protocol in this app's own reference set lists ferritin in its monitoring panel either. The other side of this trade is covered on haematocrit on TRT.

Off-label or community practice What people actually do is book a donation every eight weeks and keep doing it indefinitely, because it works, because it is free, and because nothing in the process tells them to stop. Run without a stopping rule, that is a controlled iron-depletion protocol. It is worth knowing that the finger-prick haemoglobin check at the donation centre will not catch it: that screen exists to keep the collected unit adequate and to stop donors becoming frankly anaemic, and a person can pass it repeatedly with empty stores, because haemoglobin is the last thing to fall, not the first. Whether to donate, and how often, is a prescribing decision. The ferritin trend and the donation dates belong with the clinician who prescribes your testosterone, not with the donation centre.

Ferritin is an inflammation marker as well as an iron marker

Ferritin is an acute-phase protein. Its concentration in blood rises as part of the general inflammatory response, independently of how much iron you are actually holding. That is not an occasional artefact to be waved away; it is one of the things the molecule does.

Established clinical use Inflammatory signalling raises hepcidin, which sequesters iron inside storage cells and restricts what reaches the marrow, so serum ferritin can sit comfortably in range — or above it — while iron available for making red cells is genuinely short ⁵. The size of the effect is not trivial. Pooled analyses across large population surveys found that failing to adjust ferritin for inflammation underestimates the prevalence of iron deficiency by as much as 25% ⁶. Obesity, fatty liver, heavy alcohol intake, a recent infection and hard training all push the number up. A ferritin of 90 with a CRP of 8 is not the same finding as a ferritin of 90 with a CRP of 0.4, and adding CRP to the request changes the reading more than any other single addition you can make.

Established clinical use The thresholds themselves are softer than they look. The WHO guideline places iron deficiency in apparently healthy adults below 15 µg/L, but says that where infection or inflammation is present a value below 70 µg/L may be used instead — and grades that as a conditional recommendation on low-certainty evidence ⁷. Note the width of that gap. The same result can be called deficient or not depending only on whether inflammation is assumed. Treat any 'optimal' band, including the 50–200 window this app displays, as a convenience for spotting a trend and nothing more: it is non-diagnostic, and sitting outside it is not a finding. Your own laboratory's reference interval, produced on the analyser that ran your sample, is the one that applies.

Reading iron, TIBC, transferrin and saturation together

The other four numbers describe transport rather than storage. Serum iron is the iron bound to transferrin at the moment of the draw. Transferrin is the carrier protein itself. TIBC is the total amount of iron that carrier could hold, and it is usually not measured directly — most laboratories calculate it, either from a measured unsaturated iron-binding capacity plus serum iron, or by estimating it from the transferrin concentration. Transferrin saturation is serum iron divided by TIBC, expressed as a percentage: how full the carrier is. Because it is a ratio, it inherits the error in both of its inputs.

Two patterns do most of the work. In true iron deficiency, ferritin is low, transferrin and TIBC are high — the body makes more carrier when there is less to carry — and saturation is low. In inflammation, ferritin is normal or high, serum iron is low, and transferrin and TIBC are low or low-normal, because transferrin is a negative acute-phase protein and falls as ferritin rises; saturation is low here too. Both patterns produce a low saturation. The direction TIBC and transferrin have moved is what separates them. Someone on testosterone who donates regularly and carries some metabolic inflammation can be running both patterns at once, which is precisely the situation in which reading ferritin alone goes wrong.

Established clinical use Two measurement problems are worth naming, because each one can change the interpretation of the same blood. First, serum iron and saturation are noisy: within-person biological variation is large, with coefficients of variation for serum iron that can exceed 30%, which limits the usefulness of any single transferrin saturation as a screening result and is why repeat measurement is normal practice ⁸. Second, ferritin assays are not interchangeable between analysers. A 2022 harmonisation study found between-method variation of around 23% despite manufacturers' claimed traceability to the WHO international standard, with some platforms reading tens of µg/L apart on the same serum ⁹. If your ferritin appears to have fallen after you switched laboratories, find out which analyser ran it before you conclude anything about your iron.

Established clinical use Where inflammation is muddying the picture, two tests answer the question ferritin cannot. Soluble transferrin receptor rises with cellular iron demand and is not an acute-phase protein, so it stays interpretable when ferritin does not; reticulocyte haemoglobin content reflects the iron actually being handed to newly made red cells over the preceding days rather than the preceding months ⁵. Neither appears on a standard direct-to-consumer iron panel. Both are ordinary hospital laboratory tests, and they are the right things to ask about when ferritin and CRP are pulling in opposite directions.

What low iron without anaemia does — and what the trials actually show

Established clinical use Iron deficiency without anaemia is a real state with a real symptom profile: fatigue, poor exercise tolerance, reduced work capacity and low mood in people whose haemoglobin is still perfectly normal. A systematic review of randomised trials in non-anaemic iron-deficient adults found that iron supplementation reduced subjective fatigue but did not produce a matching improvement in objective physical capacity ¹⁰. That split is the honest summary: people report feeling better, and the performance testing does not agree with them.

Established clinical use The largest trial run in exactly this population is negative, and it deserves to be quoted rather than skated over. Four hundred and five non-anaemic repeat blood donors with ferritin at or below 50 µg/L were randomised to a single large intravenous iron infusion or to placebo. Ferritin rose by a mean of 114 µg/L and haemoglobin by 5.7 g/L in the treated group — the biochemistry moved decisively — and fatigue scores six to eight weeks later were 3.9 against 4.0 out of 10, with no difference in any prespecified subgroup, including donors who started below 25 µg/L ¹¹. So the confident version you will read in forums, that a ferritin under 50 is what is making you tired, is stated far more firmly than the evidence supports. What is well established is the depletion itself: repeat donation empties iron stores reliably and predictably ²³. What is unsettled is how much of any given person's fatigue it explains, and whether refilling the stores reverses it.

Established clinical use A high ferritin has its own differential, and it matters more in this group than in most, because people who donate blood happily for years are a self-selecting population. Inflammation, obesity, alcohol and liver disease account for the majority of high results. Hereditary haemochromatosis is the one not to miss, and the screening test for it is transferrin saturation, not ferritin: a saturation above 45% captures essentially all C282Y homozygotes, and elevated iron studies are what should prompt HFE genotyping ¹². Screening roughly 100,000 primary care adults found C282Y homozygosity in 0.44% of non-Hispanic white participants, about one in 227 ¹³. A man who has been an enthusiastic donor for a decade and has always felt better for it may have been treating something without ever knowing what.

Established clinical use One further interaction, because it changes how you read the rest of your panel. Recent donation lowers HbA1c by refreshing the circulating red cell population with younger cells, while iron deficiency pushes HbA1c in the opposite direction, upward, through effects on red cell lifespan and glycation ¹⁴. Do both at once — donate on a schedule and run your ferritin down — and the two biases partly cancel by an amount you cannot recover from the number itself. This is covered further on HbA1c and fasting glucose.

None of this is material for a decision you make alone. A ferritin trend, a transferrin saturation, a TIBC, a CRP and the dates you last gave blood are the inputs to a conversation, not a conclusion. Whether to change donation cadence, whether the testosterone dose or injection frequency should be adjusted instead, whether a high ferritin needs investigating, and whether iron replacement is appropriate at all are prescribing questions — and iron given to someone who does not need it is not a harmless thing to do. Take the whole panel and the donation dates to the clinician who prescribes for you, ideally before the fatigue turns up rather than after.

What the app records for this marker

Questions people actually ask

Does TRT lower ferritin even if I never donate blood?

Yes, and it is expected. Testosterone suppresses hepcidin and raises erythropoietin, so iron is pulled out of storage and built into new red cells. Ferritin and hepcidin both fall measurably within the first one to three months of therapy while haemoglobin and haematocrit rise.

That fall is redistribution rather than loss, at least initially. Ferritin cannot distinguish the two on its own, because it drops in both cases. The way to tell them apart is to look at TIBC and transferrin alongside it: in genuine depletion the carrier proteins rise, and in simple redistribution they do not move the same way.

My ferritin is normal but I feel terrible. Could I still be iron deficient?

Possibly. Ferritin is an acute-phase protein, so inflammation, obesity, fatty liver, alcohol, a recent infection and heavy training all raise it independently of your iron. A normal-looking ferritin can sit on top of genuinely short iron supply to the marrow.

The additions that resolve this are CRP, so you know whether inflammation is in play at all, and the full transport panel — iron, TIBC, transferrin and saturation. If ferritin and CRP are pulling in opposite directions, soluble transferrin receptor and reticulocyte haemoglobin content are the tests that stay interpretable when ferritin does not. Interpreting that combination is a job for the clinician who ordered it.

How low is too low for ferritin if I donate to control my haematocrit?

There is no single number, and anyone who gives you one is overstating what is known. The WHO guideline uses below 15 µg/L in apparently healthy adults and below 70 µg/L where inflammation is present, and grades the second as a conditional recommendation on low-certainty evidence. That is a very wide band for the same measurement.

Your own laboratory's reference interval, on the analyser that ran your sample, is what applies to your result. The 50–200 band this app shows is a convenience for spotting a trend and is non-diagnostic; being outside it is not a finding on its own. What is far more informative than any single value is the direction of travel across several donations, read next to your donation dates.

Why did my ferritin change when I switched labs?

Partly because ferritin assays are not interchangeable. A 2022 harmonisation study found around 23% between-method variation despite manufacturers claiming traceability to the WHO international standard, and some analysers read tens of µg/L apart on the same serum.

So before concluding that your iron stores moved, check whether the analyser did. The practical rule is to track ferritin on one laboratory where you can, and to treat a change that coincides with a change of provider as unexplained until proven otherwise.

Should I take iron if my ferritin is low from donating?

That is a prescribing decision and it genuinely depends on why the ferritin is low, which the number alone does not tell you. Iron given to someone who does not need it is not harmless, and a high ferritin in a long-term donor has its own differential — including hereditary haemochromatosis, for which transferrin saturation rather than ferritin is the screening test.

It is also worth knowing the evidence is weaker than the community assumes. The largest randomised trial in non-anaemic iron-deficient blood donors raised ferritin and haemoglobin substantially with intravenous iron and produced no improvement in fatigue against placebo. Iron replacement, and any change to how often you donate, belong with the clinician who prescribes your testosterone.

Sources

Every claim above that is not a definition is either labelled by evidence tier or carries a numbered reference to one of these.

1. Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, Ulloor J, Zhang A, Basaria S, Ganz T, Westerman M, Bhasin S. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. Journal of Clinical Endocrinology & Metabolism, 95(10):4743–4747, 2010. Establishes that testosterone administration suppresses hepcidin and lowers ferritin as haemoglobin and haematocrit rise, which is why ferritin falls on therapy before any blood is removed.
2. Kiss JE, Vassallo RR. How do we manage iron deficiency after blood donation? British Journal of Haematology, 181(5):590–603, 2018. Quantifies the iron removed by a whole blood donation and the time required to replace it from diet alone, and describes the cumulative effect of repeat donation.
3. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion, 51(3):511–522, 2011. Source of the prevalence figures for absent iron stores and iron-deficient erythropoiesis among frequent donors, defined against a ferritin threshold of 12 ng/mL.
4. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 103(5):1715–1744, 2018. The guideline that sets the 50% and 54% haematocrit decision points and the monitoring schedule, and lists therapeutic phlebotomy among management options — without an accompanying iron-monitoring recommendation.
5. Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. International Journal of Chronic Diseases, 2018:9394060, 2018. Explains ferritin as an acute-phase reactant, the hepcidin mechanism by which inflammation raises it while restricting iron for erythropoiesis, and the role of soluble transferrin receptor and reticulocyte haemoglobin content as alternatives.
6. Namaste SM, Rohner F, Huang J, et al. Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. American Journal of Clinical Nutrition, 106(Suppl 1):359S–371S, 2017. Quantifies how much the prevalence of iron deficiency is underestimated when ferritin is not adjusted for inflammation using CRP and AGP.
7. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. World Health Organization, 2020 (Executive Summary, NCBI Bookshelf). Source of the 15 µg/L threshold for apparently healthy adults and the separate 70 µg/L threshold where infection or inflammation is present, both graded on low-certainty evidence.
8. Adams PC, Barton JC. Biological variability of transferrin saturation and unsaturated iron-binding capacity. American Journal of Medicine, 120(11):999.e1–999.e7, 2007. Documents the large within-person biological and analytical variability of serum iron and transferrin saturation, which limits their value as a single screening measurement.
9. Braga F, Pasqualetti S, Frusciante E, Borrillo F, Chibireva M, Panteghini M. Harmonization status of serum ferritin measurements and implications for use as marker of iron-related disorders. Clinical Chemistry, 68(9):1202–1210, 2022. Shows that commercial ferritin assays are not interchangeable despite claimed traceability to the WHO international standard, with between-method variation large enough to change clinical classification.
10. Houston BL, Hurrie D, Graham J, et al. Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials. BMJ Open, 8(4):e019240, 2018. Finds that iron supplementation in non-anaemic iron-deficient adults reduces subjective fatigue but does not improve objective measures of physical capacity.
11. Keller P, von Känel R, Hincapié CA, et al. The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial. Scientific Reports, 10:14219, 2020. The large negative trial in non-anaemic iron-deficient repeat donors: ferritin and haemoglobin rose substantially on intravenous iron, and fatigue scores did not differ from placebo in any subgroup.
12. Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis. American Journal of Gastroenterology, 114(8):1202–1218, 2019. Establishes transferrin saturation, with a 45% cutoff, rather than ferritin as the screening test for hereditary haemochromatosis, and that elevated iron studies should prompt HFE genotyping.
13. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. New England Journal of Medicine, 352(17):1769–1778, 2005 (HEIRS Study). Source of the C282Y homozygote prevalence of 0.44% in non-Hispanic white participants from a primary-care screening population of approximately 100,000 adults.
14. Ford ES, Cowie CC, Li C, Handelsman Y, Bloomgarden ZT. Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US. Journal of Diabetes, 2011. Supports the association between iron deficiency anaemia and higher HbA1c, the opposite direction to the bias introduced by recent blood donation.